Final safety and efficacy results of copanlisib monotherapy in patients with relapsed or refractory iNHL: 6‐year follow‐up of CHRONOS‐1.

Autor: Dreyling, M., Santoro, A., Mollica, L., Leppä, S., Follows, G. A., Lenz, G., Kim, W. S., Nagler, A., Panayiotidis, P., Demeter, J., Özcan, M., Kosinova, M., Provencio, M., Magagnoli, M., Bouabdallah, K., Heo, D. S., Diong, C. P., Munoz, J., Cao, A., Hiemeyer, F.

Publikováno v: Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p560-562, 3p

HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE PHASE III GALLIUM STUDY OF OBINUTUZUMAB-BASED AND RITUXIMAB-BASED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED INDOLENT NON-HODGKIN LYMPHOMA

Autor: Davies, A, Trask, P, Demeter, J, Florschutz, A, Hanel, M, Hong, X, Kinoshita, T, Pettengell, R, Quach, H, Robinson, S, Sadullah, S, Sancho, JM, Udvardy, M, Witzens-Harig, M, Rufibach, K, Zeuner, H, Unterhalt, M

Publikováno v: Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d8183fcfea8abea78831170742b2e7ce
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6771

Randomised phase III study of alisertib or investigator's choice (selected singe agent) in patients with relapsed or refractory peripheral T-cell lymphoma

Autor: O'connor, O, Özcan, M, Jacobsen, E, Roncero Vidal, JM, Trotman, J, Demeter, J, Masszi, T, Pereira, J, Ramchandren, R, Beaven, A, Caballero Barringon, D, Horwitz, S, Lennard, A, Turgut, M, Hamerschlak, N, d'Amore, Francesco Annibale, Foss, F, Kim, WS, Leonard, JP, Zinzani, PL, Chiattone, CS, His, ED, Liu, H, Sheldon-Waniga, E, Dansky Ullmann, C, Leonard, EJ, Shustov, A

Publikováno v: O'connor, O, Özcan, M, Jacobsen, E, Roncero Vidal, JM, Trotman, J, Demeter, J, Masszi, T, Pereira, J, Ramchandren, R, Beaven, A, Caballero Barringon, D, Horwitz, S, Lennard, A, Turgut, M, Hamerschlak, N, d'Amore, F A, Foss, F, Kim, WS, Leonard, JP, Zinzani, PL, Chiattone, CS, His, ED, Liu, H, Sheldon-Waniga, E, Dansky Ullmann, C, Leonard, EJ & Shustov, A 2017, ' Randomised phase III study of alisertib or investigator's choice (selected singe agent) in patients with relapsed or refractory peripheral T-cell lymphoma. ', Lancet Oncology .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::b0efe25f75509b7a2e9ec6fe67e7a5fc
https://pure.au.dk/portal/da/publications/randomised-phase-iii-study-of-alisertib-or-investigators-choice-selected-singe-agent-in-patients-with-relapsed-or-refractory-peripheral-tcell-lymphoma(7f9b613c-0fc5-49fa-a97b-f368d4f8af0d).html

EFFECTS OF POPULATION DATA UPDATE ON GENETIC VARIANCE OF 15 POLYMORPHIC AUTOSOMAL STR LOCI TESTED IN TRANSYLVANIA.

Autor: Demeter, J. Sz.¹ dszabolcs@yahoo.com, Kelemen, Beatrice¹, Székely, Gyöngyi², Popescu, O.^1,3

Publikováno v: Annals of the Romanian Society for Cell Biology. 2010, Vol. 15 Issue 2, p18-21. 4p. 2 Charts.

Isolation and partial characterization of the structures of fibroblast activating factor-related protein from U937 cells.

Autor: Demeter, J.¹, Medzihradszky, D.¹, Kha, H.¹, Goetzl, E.J.¹, Turck, C.W.¹

Publikováno v: Immunology. Mar91, Vol. 72 Issue 3, p350-354. 5p.